United Therapeutics Corporation Debt Securities, Available-for-sale, Realized Gain
United Therapeutics Corporation (UTHR) reported Debt Securities, Available-for-sale, Realized Gain of $400.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2025-04-30
- United Therapeutics Corporation debt securities, available-for-sale, realized gain for the quarter ending 2024-03-31 was $400.00K.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month |
|---|---|
| 2024-03-31 | $400.00K 10-Q · filed 2025-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |